U.S. Trade Distributors Stock News

NasdaqCM:LPTH
NasdaqCM:LPTHElectronic

LightPath Technologies (LPTH) Stock Retreat Deepens As Losses Eclipse Backlog Growth

LightPath Technologies stock dropped almost 5% today, extending a rough month for holders who have already seen about a one third slide over 30 days. The hit comes even as the headline story is blunt but clear. Revenue for fiscal 2026 reached about US$71.7 million and the year finished with a backlog of roughly US$110.9 million, yet the company still reported a net loss near US$20.5 million over the past twelve months. Emotion is reacting to the loss. The more important question is whether...
NYSE:MSM
NYSE:MSMTrade Distributors

MSC Industrial Direct (MSM) Could Be 8% Undervalued After Naming A New CFO

MSC Industrial Direct (MSM) has reshaped its finance leadership. The company named Robert Kuhns as Executive Vice President and Chief Financial Officer, effective September 14, 2026, replacing interim CFO Greg Clark. At a share price of $120.51, MSC Industrial Direct has delivered a 40.39% year to date share price return and a 36.91% total shareholder return over the past year, which signals strong momentum rather than a short-lived bounce. The stock has also produced a 40.40% total...
NYSE:KO
NYSE:KOBeverage

Coca Cola (KO) Could Be 7% Undervalued As Mr. Pibb Relaunch Fuels Debate

Coca-Cola (KO) has become a talking point again after the relaunched Mr. Pibb quickly turned into 2026’s fastest growing soda brand, according to Morning Consult, drawing more attention to the wider beverage portfolio. That Mr. Pibb relaunch is landing at a time when Coca-Cola’s shares have already built strong momentum, with a year to date share price return of 27.73% and a 1-year total shareholder return of 35.49%. This reflects how investors are reassessing both growth potential and...
NasdaqGS:SHOE
NasdaqGS:SHOESpecialty Retail

Shoe Station Group (SHOE) Stock Rebounds Despite Deep Margin And Sales Erosion

Shoe Station Group came into this earnings print with a bruised chart and a tired story. The stock had fallen about 27% over the past three months, yet it jumped 3.5% today after the quarterly release. That move sits against a simple reality: revenue slipped to US$284.3m and comparable store sales fell 7.1%, while earnings per share landed at US$0.23. For a footwear retailer that relies on store traffic and full price selling, the key headline today is pressure on the core store base despite...
NYSE:PLNT
NYSE:PLNTHospitality

Planet Fitness (PLNT) Stock Could Be 47% Undervalued On Subscription Cash Flow

Planet Fitness shares have dropped sharply year to date, yet both intrinsic value work and market multiples currently point to a stock that screens as cheap rather than expensive. The share price is down 53.8% year to date, which means the market has reset expectations materially even as valuation checks flag potential mispricing. Future cash generation from its largely subscription based franchise model can support value, while any slowdown in member additions or pressure on franchisee...
NYSE:EPD
NYSE:EPDOil and Gas

Enterprise Products Partners (EPD) Stock Looks Reasonable On A 152% Five Year Run

Enterprise Products Partners has quietly turned a long, strong run in the unit price into a valuation puzzle, with a powerful five year return set against a mixed overall value score and a market multiple that still screens as undervalued. For income focused investors eyeing the partnership today, the key question is whether that combination signals remaining upside or simply reflects the risk profile and cash flow profile already on display. Over the past 5 years, Enterprise Products...
NasdaqGM:IRMD
NasdaqGM:IRMDMedical Equipment

Is IRADIMED (IRMD) Overvalued After A 157% Five Year Run?

IRADIMED has delivered a strong 5 year share price run, yet its current valuation checks suggest the stock now trades at a premium to what its cash flow and market multiples imply. The share price is up about 156.7% over 5 years, which sets a high bar for any new investor looking for further gains from here. The business model, built around MRI compatible patient monitoring equipment, can support expectations for steady cash generation. However, any slowdown in unit demand or pricing could...
NYSE:KOS
NYSE:KOSOil and Gas

Kosmos Energy (KOS) Repricing Story Puts Its Undervalued Narrative Back In Focus

Kosmos Energy (KOS) has drawn attention after recent trading action, with the share price closing at US$3.02. Investors are weighing the company’s offshore exposure and current valuation metrics against its recent return profile. The recent 20.32% 1 month share price return and 8.63% 7 day move suggest short term momentum is building in Kosmos Energy, although the 3 year total shareholder return decline of 57.94% contrasts with a 24.28% gain over five years, underscoring a mixed longer term...
NasdaqGS:HLNE
NasdaqGS:HLNECapital Markets

Hamilton Lane (HLNE) Stock Looks Reasonable On Earnings While Broader Checks Stay Mixed

Hamilton Lane stock has fallen sharply over the past year, yet the valuation checks paint a more mixed picture that does not clearly tag the shares as either a bargain or obviously expensive. For investors, the recent slide raises the question of whether the current price fairly reflects the business or leans too pessimistic. Over the past 12 months, Hamilton Lane has declined 34.2%, which puts recent sentiment under pressure despite longer term gains over 3 and 5 years. Earnings power tied...
NasdaqGS:IONS
NasdaqGS:IONSBiotechs

Ionis Pharmaceuticals (IONS) On Mixed Trial And FDA News While The Undervalued Narrative Holds

Ionis Pharmaceuticals (IONS) is back in focus after mixed trial and regulatory headlines. Partner Novartis reported that the pelacarsen Lp(a)HORIZON Phase 3 trial did not meet its primary endpoint, while Ionis secured FDA approval for rare disease therapy ZANVASTRO. At a share price of $54.21, Ionis Pharmaceuticals has seen momentum cool, with the stock down 26.02% on a 90 day share price return and the 1 year total shareholder return also lower, despite multi year total returns still...
NasdaqGM:IOVA
NasdaqGM:IOVABiotechs

Iovance Biotherapeutics (IOVA) Dropped, So What Is Driving Attention Now?

Iovance Biotherapeutics (IOVA) is set to present at the Wells Fargo 21st Annual Healthcare Conference on September 10, 2026. This event will give investors fresh commentary to weigh against the stock’s recent performance. Iovance Biotherapeutics has seen sharp swings recently, with the share price falling 3.44% over the last day and 6.44% over the week, while recording a 223.02% year-to-date share price return and a 236.36% total shareholder return over one year. This performance may be...
NYSE:LEU
NYSE:LEUOil and Gas

Centrus Energy (LEU) Stock Could Be Stretched After A Fresh HALEU Supply Deal

Centrus Energy stock has delivered a very strong 314.2% gain over the past 5 years, yet on broad valuation checks it now screens as expensive rather than a clear bargain. After a sharp pullback this year, the key issue for investors is whether that earlier run still reflects the fundamentals or whether expectations have moved ahead of what the business can reasonably justify. A 314.2% return over 5 years highlights how powerful the long term move in Centrus Energy has been, even with the...
NasdaqGS:CRWV
NasdaqGS:CRWVIT

CoreWeave (CRWV) Stock May Be Undervalued Following Its 21% Slide

CoreWeave stock has had a difficult year, with the share price down 20.5% over the past 12 months even as some valuation checks still flag it as undervalued on market multiples. At the same time, a low overall value score suggests the broader set of indicators does not yet point to a clear bargain. The 1 year return has declined 20.5%, which signals that investors who bought a year ago are sitting on sizeable paper losses. New AI cloud projects such as Physical AI Field Engineering and the...
NasdaqGS:CSGP
NasdaqGS:CSGPReal Estate

CoStar Group (CSGP) Homes.com Survey Keeps Fair Value In Focus

Homes.com survey puts consumer behavior in focus for CoStar Group stock A new Homes.com survey from CoStar Group (CSGP) on new construction buyers shows shoppers coming to the market more informed, expecting larger properties, and emphasizing long term financial confidence and customization. Recent trading has been rough for CoStar Group, with the share price down 6.9% over the past week and roughly 55.1% lower year to date, while the 1 year total shareholder return has fallen 66.1%. This...
NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Biogen (BIIB) Sees Canada Back LEQEMBI As Fair Value Stays In Focus

Eisai and Biogen (BIIB) just cleared a key hurdle in Canada, with the national drug agency issuing a final recommendation supporting public reimbursement for Alzheimer’s therapy LEQEMBI for eligible early stage patients. For investors, the LEQEMBI update comes at a time when Biogen’s momentum has been rebuilding, with a 1-day share price return of 2.23% and a year-to-date share price return of 21.15%, while the 1-year total shareholder return of 44.74% contrasts with declines in the 3- and...
NYSE:SOC
NYSE:SOCOil and Gas

3 U.S. Energy Stocks With Direct Oil Price Exposure

Inflation is still running hot, gasoline prices are climbing and oil back above $100 is putting fresh pressure on the Federal Reserve ahead of its September meeting. That mix can reshuffle which U.S. energy stocks investors pay attention to and which get left behind. This article walks through three stocks from our U.S. Energy Sector Stocks screener that appear especially exposed to these developments and explains why their next moves could matter for a diversified portfolio. The three stocks...
NYSE:UPS
NYSE:UPSLogistics

Is United Parcel Service (UPS) Below Fair Value Despite Strike Risk?

United Parcel Service stock has delivered a loss of 33.2% over the past five years, yet current valuation checks suggest the shares may now trade below what the intrinsic value estimate implies. The Discounted Cash Flow (DCF) workup points to an undervalued profile that lines up with the market multiple checks, while the long term price record still looks weak. Over five years, the share price has declined 33.2%, which puts long term holders in the red even after a stronger 1 year patch. On...
NasdaqGS:ADP
NasdaqGS:ADPProfessional Services

Can Automatic Data Processing (ADP) Still Justify A Premium After Slower Hiring?

Automatic Data Processing stock has delivered a 5 year gain of 51.0%, yet current valuation checks suggest the shares are now closer to fairly priced than obviously cheap. The Discounted Cash Flow (DCF) intrinsic value estimate and market multiples both sit roughly in line with where the market is pricing the business today. Over the past 5 years, Automatic Data Processing has returned 51.0%, which reflects meaningful long term value creation already embedded in the share price. The...
NasdaqGS:NWL
NasdaqGS:NWLConsumer Durables

Newell Brands (NWL) Looks Fully Valued As Margin Recovery Hopes Build

Newell Brands (NWL) has drawn fresh attention after recent share moves, with the price closing at US$5.87. Investors are weighing short term declines against longer term swings in performance. Recent trading has cooled after a strong run, with Newell Brands showing a 1 day share price return of down 2.17% and a 7 day move of down 3.29%. However, the 90 day share price return of 19.31% and year to date gain of 57.80% indicate momentum that has built over several months, while the 5 year total...
NYSE:DRI
NYSE:DRIHospitality

Darden Restaurants (DRI) On Its Smaller Format Push And The Case For Undervaluation

Darden Restaurants (DRI) has been drawing attention after recent share price softness, with the stock down over the past week, month, and past 3 months despite positive annual revenue and net income growth. Short term momentum for Darden Restaurants has cooled, with the share price declining over the past week and month. However, the year to date share price return of 10.85% and a 3 year total shareholder return of 50.71% reflect a much stronger longer run trajectory. Scan beyond Darden...
NYSE:HWM
NYSE:HWMAerospace & Defense

Howmet Aerospace (HWM) Could Be 30% Undervalued On Casting Deal Jitters

Event driven move puts Howmet Aerospace in focus Howmet Aerospace (HWM) dropped roughly 10% after GE Aerospace agreed to buy casting specialist Consolidated Precision Products for about US$11.75b, raising questions about future engine component demand relationships. The latest pullback adds to a tougher stretch for Howmet Aerospace, with the share price down 12.5% over the past week and 19% over the past month. However, the 1-year total shareholder return of 24% and very large 5-year total...
NYSE:JNJ
NYSE:JNJPharmaceuticals

Is Johnson & Johnson (JNJ) Resetting Its Device Business With Two Fresh Moves?

Johnson & Johnson (NYSE:JNJ) received CE Marking in Europe for its ACUVUE OASYS MAX reusable contact lenses for digital device users. Jaguar LAA, Inc. agreed to acquire Johnson & Johnson’s Laminar left atrial appendage closure program assets from its MedTech portfolio. The Laminar transfer shifts development of the left atrial appendage closure device to Jaguar LAA, while Johnson & Johnson reallocates resources. The ACUVUE OASYS MAX approval and Laminar divestment only capture part of what...
NYSE:MGY
NYSE:MGYOil and Gas

Magnolia Oil And Gas (MGY) Stock Looks Fairly Valued Following Its 79% Five Year Run

Magnolia Oil & Gas has delivered a strong 79.2% return over the past 5 years, yet the valuation checks send a mixed message that keeps the stock from looking like a straightforward bargain or a clear excess. A 79.2% gain over 5 years suggests Magnolia Oil & Gas has already rewarded patient holders, so fresh capital now needs a clear view on what is priced in. Future value can hinge on how consistently Magnolia Oil & Gas converts its production into free cash flow. Sensitivity to commodity...
NYSE:KBR
NYSE:KBRProfessional Services

How Investors May Respond To KBR (KBR) Three Year Defense Contract Win

KBR reported that its Mission Technology Solutions business, set to become Trinzic after a planned spin off, secured a three year U.S. government contract to continue mission critical radio frequency engineering, manufacturing and modernization work supporting national security systems. The award highlights that KBR’s soon to be separated mission technology segment is still winning complex, defense grade work requiring integrated engineering, manufacturing, supply chain and quality...